Leah R. Zuroff

Neurology

2330 Post St
San Francisco, CA 94115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

Journal: JAMA neurology

Published: August 17, 2026

Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.

Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 30, 2026

Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Remyelination therapies are achievable in clinical practice-Yes.

Remyelination therapies are achievable in clinical practice-Yes.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 05, 2025

The Road to Remyelination in Multiple Sclerosis: Breakthroughs, Challenges, and Considerations for Future Trial Design.

The Road to Remyelination in Multiple Sclerosis: Breakthroughs, Challenges, and Considerations for Future Trial Design.

Journal: Drugs

Published: July 03, 2025

Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations.

Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations.

Journal: bioRxiv : the preprint server for biology

Published: October 17, 2024

The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair.

The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: April 24, 2024

Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort

Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort

Journal: Neurology

Published: January 23, 2024

Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States.

Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States.

Journal: Neurology. Clinical practice

Published: January 10, 2024

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis.

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 05, 2023

Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.

Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.

Journal: EBioMedicine

Published: February 14, 2023

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 12, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026